P2RX7 and myeloid sarcoma: Patients with MS show increased expression of P2X7 receptor in normal-appearing axon tracts [62], reactive astrocytes [131] and neurons and astrocytes during an acute EAE phase [63,64], which suggests their participation in the development of the disease.